Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.

@article{Giannantoni2004IntravesicalRV,
  title={Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.},
  author={Antonella Giannantoni and Savino M Di Stasi and Robert L. Stephen and Vittorio Bini and Elisabetta Costantini and Massimo Porena},
  journal={The Journal of urology},
  year={2004},
  volume={172 1},
  pages={240-3}
}
PURPOSE We investigated the effectiveness and safety of intravesical resiniferatoxin (Sigma Chemical Co., St. Louis, Missouri) and botulinum-A toxin injections into the detrusor muscle in a group of spinal cord injured patients with neurogenic detrusor overactivity unresponsive to conventional anticholinergic therapy. MATERIALS AND METHODS A total of 25 patients were randomly assigned to receive intravesically 0.6 microM resiniferatoxin in 50 ml of 0.9% NaCl or injections into the detrusor… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

OnabotulinumtoxinA for neurogenic detrusor overactivity and dose differences: a systematic review.

International braz j urol : official journal of the Brazilian Society of Urology • 2015
View 10 Excerpts
Highly Influenced

Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.

Toxicon : official journal of the International Society on Toxinology • 2013
View 3 Excerpts
Highly Influenced

Consultation in Neurourology

Springer International Publishing • 2018
View 2 Excerpts

Botulinum toxin type A injection for neurogenic detrusor overactivity: clinical outcome in Japanese patients.

International journal of urology : official journal of the Japanese Urological Association • 2013

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Similar Papers

Loading similar papers…